论文部分内容阅读
尽管替米沙坦的表现十分突出(极其接近雷米普利),但受试验设计的限制,只能说是ACEI的有效替代药物。替代不等于取代,因为血管紧张素Ⅱ受体拮抗剂(ARB)并不是不“咳嗽”的ACEI。
Although telmisartan performs very well (very close to ramipril), the limitations of experimental design can only be described as effective alternatives to ACEI. Substitutions are not equal to substitutions because angiotensin II receptor antagonists (ARBs) are not ACEIs that do not “cough.”